AZBio Board of Directors
Jyotsna Ghai, PhD
Global Head, Vice President Product Development
Jyotsna is an accomplished executive with over 25 years of biomedical industry experience which includes successfully leading challenging technical and high visibility strategic programs through large multi-functional teams towards the development of implantable devices, drug-device combination/cross-labeled products, in vitro diagnostics instruments and assays.
In her current role as the Global Head and VP Product Development, Roche Tissue Diagnostics (Pathology & Oncology) she leads product development functions including Oncology and Personalized healthcare Solutions, Assay Research Development, Systems Engineering, Software Engineering, and Digital Pathology.
Past roles include VP of Biosurgery Research and Development at Johnson and Johnson where she led global R&D teams (US, China, Israel) and was responsible for all aspects of R&D for the Biosurgery business, including class II and III medical devices and Combination Products. Prior to this, she led R&D teams for Sanofi (US, France and Germany), Medtronic and Beckman Coulter.
At Medtronic, she assumed various positions of increasing responsibility across the Cardiac Surgery, and Neuromodulation divisions. In her role at Neuromodulation, she led the development of Implantable Infusion Systems, where she established the vision, strategy, and business case for the platform and drove cross-functional execution for one of the largest and most complex programs within Medtronic. At Beckman Coulter Inc. / Sanofi Diagnostics Pasteur, Inc. she led antibody engineering and bioprocess R&D teams to develop in-vitro diagnostics.
Jyotsna has a Master’s of Science and Ph.D. in Microbiology from Punjab A. University. She completed her post-doctoral work at the National Center for Scientific Research (CNRS) in France in molecular biology and at the University of Minnesota on the molecular basis of tumorigenesis and oncology. She later obtained staff position at the University of Minnesota at the institute of Human Genetics, University of Minnesota Medical School and led a research team through NIH and NCI grants to elucidate the mechanism of oncogensis by HPV11.
Through executive education, Jyotsna acquired concentrations in Marketing, Strategy & Finance, and Management at UCLA, Wharton and Stanford, respectively.